CSPC Pharmaceutical-UnspoadrCSPCY
13F holders, Q2 2024 (June 30)2holders −1
0new positions
1sold out
$3.11avg. 13F price*
At the end of Q2 2024, 2 institutions reported holding CSPC Pharmaceutical-Unspoadr (CSPCY) in their 13F filings, down 1 from Q1 2024. 0 opened new positions and 1 sold out. The largest holders were Rhumbline Advisers ($81K) and PNC Financial Services Group, Inc. ($1K).
- Company
- CSPC Pharmaceutical-Unspoadr
- Filed as
- 1SPC PHARM ADR (Q2 2024)
- CUSIP
- 12591J207
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $6K |
All 13F filers, Q1 2024 → Q2 2024: 141 shares bought and 2,030 shares sold, net −1,889 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Rhumbline Advisers | 0.00% | No change | 26,068 | $81K |
| PNC Financial Services Group, Inc. | 0.00% | Add +67.8% | 349 | $1K |
"% of holder's portfolio" is CSPCY's weight in each manager's 13F, not the share of CSPC Pharmaceutical-Unspoadr the manager owns.